Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-01

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.)

NCT06180005

Non Small Cell Lung Cancer

RECRUITING

Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling

NCT02407327

Advanced Non Small Cell Lung Cancer

COMPLETED

Lung Cancer Prevention Screening Programme in Italy

NCT05766046

Lung Cancer COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection Cardiovascular Diseases

RECRUITING NA

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

NCT06467383

Non-small Cell Lung Cancer NSCLC NSCLC, Stage III +1 more

RECRUITING

Radiomics and Radiogenomics of Non-small Cell Lung Cancer

NCT06331975

Non Small Cell Lung Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Stage IV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Advanced lung cancer patients' group

Evaluation of the demographic, clinical, histological and molecular characteristics of advanced lung cancer at the time of Diagnosis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Suspicion of lung cancer based on imaging (CT and/or PET/CT)
* Indication to a biopsy for diagnosis, staging and/or molecular profiling

Exclusion Criteria

* Inability or unwillingness to provide a written informed consent
* ECOG performance status (\>3) which makes a tissue diagnosis unfeasible
* ASA 4 status
* TNM Stage I-III

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No